1.Date of occurrence of the event:2022/11/23
2.Company name: OBI Pharma Inc.
3.Relationship to the Company (please enter ”headoffice” or ”subsidiaries”):
OBI Pharma Australia Pty Ltd (The wholly owned subsidiary of the Company; hereinafter referred to as OBI Australia.)
OBI Pharma (Shanghai) Limited (The wholly owned sub-subsidiary of the Company; hereinafter referred to as OBI Shanghai.)
4.Reciprocal shareholding ratios: Not applicable
5.Cause of occurrence: The Company mistakenly announced the monetary loan balance of OBI Australia to OBI Shanghai in September and October 2022
as 3,175 thousand dollars and 3,222 thousand dollars, respectively. The balance was hereby corrected as 0 thousand dollars and 0 thousand dollars.
6.Information items/ statements to be corrected: Information on monetary loan balance and report.
7.Amounts/ contents/ number of page to be corrected:
Ending balance to be corrected in September 2022: 3,175 thousand dollars
Ending balance to be corrected in October 2022: 3,222 thousand dollars
8.Amounts/ contents/ number of page after correction:
Ending balance after correction in September 2022: 0 thousand dollars
Ending balance after correction in October 2022: 0 thousand dollars
9.Countermeasures:Not applicable
10.Any other matters that need to be specified:
Correct the monetary loan report of September and October 2022 and re-upload the information to the Market Observation Post System (MOPS).